CIK 0000718937
- Large accelerated filer
STAAR SURGICAL CO
Sign in to watch- Ticker
- STAA
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Jan 2
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953797439
- Phone
- +1 626-303-7902
- Business address
- 1911 WALKER AVE, MONROVIA, CA, 91016
- Former names
- STAAR SURGICAL COMPANY
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −20,000 | 0 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −20,000 | 0 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −20,000 | 0 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −21,875 | 625 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −50,000 | 0 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −20,000 | 0 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −12,500 | 0 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −13,333 | 6,667 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −6,292 | 4,495 | ||
| 2020-05-21 | Gesten Samuel J Chief Legal Officer | Exercise or conversion · Common Stock Options | −8,522 | 14,374 | ||
| 2020-05-15 | Holliday Keith Chief Technology Officer | Exercise or conversion | +25,000 | $7.20 | $180K | 53,447 |
| 2020-05-15 | Holliday Keith Chief Technology Officer | Sale | −25,000 | $37.69 | $942K | 28,447 |
| 2020-05-15 | Holliday Keith Chief Technology Officer | Exercise or conversion · Common Stock Options | −25,000 | 0 | ||
| 2020-05-13 | Francese James E Sr. VP, Comm. Ops., NA, APAC | Exercise or conversion | +6,667 | $5.34 | $36K | 51,133 |
| 2020-05-13 | Francese James E Sr. VP, Comm. Ops., NA, APAC | Exercise or conversion · Common Stock Options | −6,667 | 13,333 | ||
| 2020-05-11 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +21,294 | $9.30 | $198K | 32,088 |
| 2020-05-11 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +19,178 | $7.52 | $144K | 51,266 |
| 2020-05-11 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +6,091 | $8.64 | $53K | 57,357 |
| 2020-05-11 | Hayashida Jon K. VP, Global Clinical, Medical | Sale | −46,563 | $39.11 | $1.8M | 10,794 |
| 2020-05-11 | Hayashida Jon K. VP, Global Clinical, Medical | Grant or award · Common Stock Options | +21,294 | 16,206 |
Page 43 of 50 · 987 trades